AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (639)	9/1/1997 7:29:00 PM
From: D.Right	of 2173

Dear Henry: If you are right (apparantly I don't think so), isn't it silly for LGND even to try to sign any deal for diabetes and to conduct any more clinical trials? They can just wait to have patients use Targretin off label and forget about any further work if it gets approvals for cancer treatments. I also think it is too carried away to say patient will DEMAND to use it off label based on now still not known data from one clinical II (of course, if all patients have the same first name like Henry, who knows?). To me, to say a drug can be used off label and beat an in-label drug is like to predict that Michael Jordan can play in the major league baseball and hit home-runs all the time. It is not reasoning. It is even beyond speculations. It can only happen in a wild dream. We all know Jordan is still the greatest BASKETBALL player in the world. Enjoy your LGND ride and stop putting down pramlintide. D.Right

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next